Half a century of antipsychotics and still a central role for dopamine D2 receptors.
about
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.The neurodevelopmental hypothesis of schizophrenia, revisitedAnalogues of the dopamine D2 receptor antagonist L741,626: Binding, function, and SARAntipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanismsAripiprazole: from pharmacological profile to clinical useA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesAn Overview of the Association between Schizotypy and Dopamine.Transcriptional regulation of GAD1 GABA synthesis gene in the prefrontal cortex of subjects with schizophreniaUpdate on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor AntagonismDrug models of schizophreniaPharmacological actions of NGB 2904, a selective dopamine D3 receptor antagonist, in animal models of drug addiction(-)-Stepholidine is a potent pan-dopamine receptor antagonist of both G protein- and β-arrestin-mediated signalingFeasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study.Transcranial direct current stimulation in schizophreniaTAK-063, a PDE10A Inhibitor with Balanced Activation of Direct and Indirect Pathways, Provides Potent Antipsychotic-Like Effects in Multiple ParadigmsInhibition of phosphodiesterase 10A has differential effects on dopamine D1 and D2 receptor modulation of sensorimotor gating.PDE10A inhibitors stimulate or suppress motor behavior dependent on the relative activation state of the direct and indirect striatal output pathwaysPhosphodiesterase 10A inhibitor MP-10 effects in primates: comparison with risperidone and mechanistic implicationsRole of the dopaminergic system in the acquisition, expression and reinstatement of MDMA-induced conditioned place preference in adolescent miceActivation of the canonical Wnt pathway by the antipsychotics haloperidol and clozapine involves dishevelled-3Lentiviral-mediated gene delivery reveals distinct roles of nucleus accumbens dopamine D2 and D3 receptors in novelty- and light-induced locomotor activityProfound changes in dopaminergic neurotransmission in the prefrontal cortex in response to flattening of the diurnal glucocorticoid rhythm: implications for bipolar disorderSchizophrenia, "Just the Facts" 6. Moving ahead with the schizophrenia concept: from the elephant to the mouseImpaired musical ability in people with schizophrenia.Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotectionEffects of the nicotinic α7 receptor partial agonist GTS-21 on NMDA-glutamatergic receptor related deficits in sensorimotor gating and recognition memory in ratsThe moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine.Neurodevelopmental animal models of schizophrenia: role in novel drug discovery and developmentHow antipsychotics work-from receptors to reality.The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal modelsModeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspectsThe evolution of drug development in schizophrenia: past issues and future opportunities.Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?A sex- and region-specific role of Akt1 in the modulation of methamphetamine-induced hyperlocomotion and striatal neuronal activity: implications in schizophrenia and methamphetamine-induced psychosisNeuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.Optogenetics in psychiatric animal models.Tardive dyskinesia in relation to estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data.Antipsychotic drug action: targets for drug discovery with neurochemical imaging.Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiencyTowards the clinical implementation of pharmacogenetics in bipolar disorder.
P2860
Q24609188-37ABBD16-CAA7-41A0-9A37-51426B2368D1Q24658343-7FAE1059-3482-4189-9AE0-4D779E9EDB9DQ24683864-120CCD15-49D4-40C3-A3AD-047482A8A771Q26745506-D8EB35A6-762C-4D57-89CE-FA5CCB3F8478Q26778312-9970C928-70F0-4B21-8798-126E2ADFBD8FQ26786354-3615C5F7-D8C3-443E-A19D-AC481773E1B6Q26991569-0DA8FDDC-C12A-474A-9DF6-D33614DA5BC9Q26991794-08005B1C-0F2B-411E-BF08-8811B0906873Q28084069-6CF0D613-2988-4F02-A342-704562E65438Q28084198-14DF56A4-8768-4EA6-8053-2634CCEF8E01Q28236375-ED9AC8DD-3F97-44D6-823C-737D585A87F0Q28248215-97DCD650-2D9E-4949-B72B-DFBC9A08CC8CQ28277784-C598D483-C12F-4455-8642-ECAA211D8418Q28306647-A86ADD08-C3DE-4196-8F62-D92558AAEF2DQ28384192-F036A98D-7754-4299-9FC9-33E0A04AEC72Q28385659-0FE2F7C3-B8C0-4770-BB1C-8A7ACC2CF74DQ28395353-73F99A25-701D-4D5E-8176-C46F35BBFA4DQ28396609-3E1EEDC0-7228-4A92-BAF6-8AABDE2BFBF4Q28482310-CBEC3D79-D7D5-495B-89B4-B95A52E9F31EQ28567705-2F65BEFB-6E3D-43D8-9B96-73D7F4621340Q28579950-353E21EF-8544-40D8-9994-62CFFE6D3A70Q28583351-7F2174D0-B7AC-4D6B-9E20-6DEFF029D596Q28727394-2E644006-AC02-46B3-9C5F-A60CECFF0717Q30354449-5ABE1912-57E3-4B98-A910-B326167CD340Q30386608-86082DBA-215A-4540-BABA-ABD66B431CE6Q30391389-6ECFF730-904E-4404-909F-131778929263Q30404784-483C4062-C707-4C95-94A0-543481854791Q30414108-E190754F-4B59-4335-A842-6D6F140BD01DQ30457477-11FB9C82-BDCE-49FA-B1E6-631C0A7127D3Q30470041-0A93799D-A55E-4D60-9D45-F9A0BF98E67BQ30476813-BA141996-49FA-4444-B504-ACA6481913FFQ30487850-11044DA1-FBBB-4232-9C35-2D582AEEEDDEQ30491317-F2563539-868E-4C21-9851-E674F17AF6D0Q30572456-848482E4-5ECD-4AA4-B68C-94C681E8B328Q30582343-543B44AF-61A9-4AA6-A0CD-2406EB8D3214Q30630496-2383FE9F-FEE7-4F12-AFD6-2C2F9A1118EBQ30747608-DFC4FBE4-BFAA-4D33-8DCA-8DA09164D4E9Q31032036-3836376B-49D1-40F2-A652-6B39E2281D91Q33342753-CC36CA71-996D-41D4-8A44-12EB5DDE41B4Q33688133-0ACDDCFE-638F-420F-88DC-C376914F6825
P2860
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@ast
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@en
type
label
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@ast
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@en
prefLabel
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@ast
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@en
P1476
Half a century of antipsychotics and still a central role for dopamine D2 receptors.
@en
P2093
David Mamo
P304
P356
10.1016/J.PNPBP.2003.09.004
P50
P577
2003-10-01T00:00:00Z